GL
Therapeutic Areas
Corvus Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Soquelitinib (CPI-818) | Relapsed/Refractory T Cell Lymphomas | Phase 1/1b |
Leadership Team at Corvus Pharmaceuticals
RA
Richard A. Miller, M.D.
President, CEO, Co-Founder
LL
Leiv Lea
Chief Financial Officer
JA
Jeffrey Arcara
Chief Business Officer
OA
Otute Akiti, Ph.D.
Vice President, CMC
WB
William Ben Jones, Ph.D.
Senior Vice President, Pharmaceutical Development